Latest Breaking News On - Launch therapeutics - Page 3 : comparemela.com

Opthea Expands Leadership Team with the Appointment of Timothy E Morris as Chief Financial Officer

Opthea Expands Leadership Team with the Appointment of Timothy E Morris as Chief Financial Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSam martinTimothye morrisRudi michelsonMegan baldwinIovance biotherapeuticsQuestcor pharmaceuticals incAcelrx pharmaceuticalsHumanetics corporationInvestment in biotechnology companiesHumanigen incCompany media enquiriesMonsoon communicationsCalifornia state universityOpthea limitedWall street

Opthea Expands Leadership Team with the Appointment of Timothy E Morris as Chief Financial Officer

United statesRudi michelsonmonsoon communicationstelTimothye morrisMegan baldwinIovance biotherapeuticsQuestcor pharmaceuticals incAcelrx pharmaceuticalsHumanetics corporationInvestment in biotechnology companiesHumanigen incCompany media enquiriesCalifornia state universityOpthea limitedChief financial officerChief executive officerManaging director

Opthea Reports Fiscal Year 2022 Financial Results and Corporate Highlights

30.08.2022 - Secured up to US$170m in non-dilutive financing Received commitments for well supported US$90m equity financing; closed first tranche for US$41.9 million Expanded management team and US operations with appointment of C-Suite Executives Elected . Seite 1

Judith robertsonQuinton oswaldJoel naorMegan baldwinSusan orrOpthea limitedManaging directorLaunch therapeuticsChief medical officerChief commercial officerOpthea board

Opthea Successfully Closes Well Supported US$90 Million Equity Financing

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesNew zealandNew zealand generalSam martinRudi michelsonSilvana guerci lenaMegan baldwinBiotechnology companiesExchange commissionMonsoon communicationsOpthea limitedNew sharesNew sharePlacement priceVolume weighted average priceLaunch therapeutics

Opthea Successfully Closes Well Supported US$90 Million

MELBOURNE, Australia, Aug. 14, 2022 (GLOBE NEWSWIRE) Opthea Limited (ASX:OPT; NASDAQ: OPT) (Opthea), a clinical stage biopharmaceutical company.

United statesNew zealandNew zealand generalSam martinRudi michelsonSilvana guerci lenaMegan baldwinBiotechnology companiesExchange commissionMonsoon communicationsOpthea limitedNew sharesNew sharePlacement priceVolume weighted average priceLaunch therapeutics